Endocrine Metabolic & Immune Disorders - Drug Targets
Bentham Science Publishers · Q3
ISSN: 1871-5303 · 2212-3873
Rankings & quartile
| System | Value | Year | Source |
|---|---|---|---|
| SCImago (SJR) | 0.552 Q3 | 2025 | source |
| Citation impact (OpenAlex) | 12.9 cites/work Q4 | 2026 | source |
| h-index | 66 | 2026 | source |
Last updated 2026-05-19 · OpenAlex profile
Cite this profile
APA 7Journal Check. (2026). Endocrine Metabolic & Immune Disorders - Drug Targets: Journal rankings & quartile. Journal Check. https://journal-check.com/journals/S4210179974/endocrine-metabolic-immune-disorders-drug-targets MLA 9"Endocrine Metabolic & Immune Disorders - Drug Targets: Journal rankings & quartile." Journal Check, 2026, https://journal-check.com/journals/S4210179974/endocrine-metabolic-immune-disorders-drug-targets. Chicago 17Journal Check. "Endocrine Metabolic & Immune Disorders - Drug Targets: Journal rankings & quartile." 2026. https://journal-check.com/journals/S4210179974/endocrine-metabolic-immune-disorders-drug-targets. GB/T 7714Journal Check. Endocrine Metabolic & Immune Disorders - Drug Targets: Journal rankings & quartile[EB/OL]. (2026). https://journal-check.com/journals/S4210179974/endocrine-metabolic-immune-disorders-drug-targets.See rankings while you search
Journal Check shows this journal's quartile right next to its papers on Google Scholar, PubMed, arXiv and Semantic Scholar.
Add to Chrome — free